Editorial: Spatial immune cell heterogeneity in the tumor microenvironment.
作者信息
Ganguly Anirban, Mukherjee Sumit, Spada Sheila
机构信息
Department of Biochemistry, All India Institute of Medical Sciences, Deoghar, Jharkhand, India.
Actinium Pharmaceuticals, Inc., New York, NY, United States.
出版信息
Front Immunol. 2024 Feb 21;15:1377532. doi: 10.3389/fimmu.2024.1377532. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Spatial immune cell heterogeneity in the tumor microenvironment.
Front Immunol. 2024 Feb 21;15:1377532. doi: 10.3389/fimmu.2024.1377532. eCollection 2024.
2
Emerging organoid-immune co-culture models for cancer research: from oncoimmunology to personalized immunotherapies.
J Immunother Cancer. 2023 May;11(5). doi: 10.1136/jitc-2022-006290.
3
The Single-Cell Level Perspective of the Tumor Microenvironment and Its Remodeling by CAR-T Cells.
Cancer Treat Res. 2022;183:275-285. doi: 10.1007/978-3-030-96376-7_10.
4
Nanoengineered CAR-T Biohybrids for Solid Tumor Immunotherapy with Microenvironment Photothermal-Remodeling Strategy.
Small. 2021 Apr;17(14):e2007494. doi: 10.1002/smll.202007494. Epub 2021 Mar 12.
5
Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies.
J Biomed Sci. 2024 Jan 12;31(1):5. doi: 10.1186/s12929-024-00998-8.
6
Immune Checkpoints and CAR-T Cells: The Pioneers in Future Cancer Therapies?
Int J Mol Sci. 2020 Nov 5;21(21):8305. doi: 10.3390/ijms21218305.
7
A drug screening to identify novel combinatorial strategies for boosting cancer immunotherapy efficacy.
J Transl Med. 2023 Jan 13;21(1):23. doi: 10.1186/s12967-023-03875-4.
8
An Ex Vivo 3D Tumor Microenvironment-Mimicry Culture to Study TAM Modulation of Cancer Immunotherapy.
Cells. 2022 May 8;11(9):1583. doi: 10.3390/cells11091583.
9
JAK/STAT-Dependent Chimeric Antigen Receptor (CAR) Expression: A Design Benefiting From a Dual AND/OR Gate Aiming to Increase Specificity, Reduce Tumor Escape and Affect Tumor Microenvironment.
Front Immunol. 2021 Jun 9;12:638639. doi: 10.3389/fimmu.2021.638639. eCollection 2021.
10
Revolutionizing cancer immunotherapy in solid tumor: CAR engineering and single-cell sequencing insights.
Front Immunol. 2023 Nov 23;14:1310285. doi: 10.3389/fimmu.2023.1310285. eCollection 2023.
引用本文的文献
1
Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches.
Signal Transduct Target Ther. 2025 Jul 31;10(1):227. doi: 10.1038/s41392-025-02280-1.
2
Defining and modeling dynamic spatial heterogeneity within tumor microenvironments.
Curr Opin Cell Biol. 2024 Oct;90:102422. doi: 10.1016/j.ceb.2024.102422. Epub 2024 Aug 30.
3
Current Landscape of Cancer Immunotherapy: Harnessing the Immune Arsenal to Overcome Immune Evasion.
Biology (Basel). 2024 Apr 28;13(5):307. doi: 10.3390/biology13050307.
本文引用的文献
1
Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer.
J Clin Oncol. 2024 Apr 10;42(11):1311-1321. doi: 10.1200/JCO.23.00580. Epub 2024 Jan 11.
2
Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors.
Biology (Basel). 2023 Jan 30;12(2):218. doi: 10.3390/biology12020218.
3
Mechanisms of Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Patients with Hepatocellular Carcinoma.
Cancers (Basel). 2022 Sep 23;14(19):4616. doi: 10.3390/cancers14194616.
4
Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance.
Int J Biol Sci. 2022 Apr 24;18(7):3019-3033. doi: 10.7150/ijbs.72534. eCollection 2022.
5
Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancer.
Sci Transl Med. 2022 Mar 16;14(636):eabe8195. doi: 10.1126/scitranslmed.abe8195.
6
Mechanisms of Cancer Resistance to Immunotherapy.
Front Oncol. 2020 Aug 6;10:1290. doi: 10.3389/fonc.2020.01290. eCollection 2020.
7
Mechanisms of immune escape in the cancer immune cycle.
Int Immunopharmacol. 2020 Sep;86:106700. doi: 10.1016/j.intimp.2020.106700. Epub 2020 Jun 23.
8
Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance.
Cancer Cell. 2020 Apr 13;37(4):471-484. doi: 10.1016/j.ccell.2020.03.007.
9
Spatial Heterogeneity in the Tumor Microenvironment.
Cold Spring Harb Perspect Med. 2016 Aug 1;6(8):a026583. doi: 10.1101/cshperspect.a026583.
Zotero 插件